You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Isosulfan blue - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for isosulfan blue and what is the scope of patent protection?

Isosulfan blue is the generic ingredient in two branded drugs marketed by Am Regent, Beloteca, Eugia Pharma, Fresenius Kabi Usa, Meitheal, MSN, Mylan Institutional, Somerset Theraps Llc, and Covidien, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for isosulfan blue. Five suppliers are listed for this compound.

Summary for isosulfan blue
Drug Prices for isosulfan blue

See drug prices for isosulfan blue

Recent Clinical Trials for isosulfan blue

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
OnLume Inc.N/A
National Institutes of Health (NIH)N/A
University of Wisconsin, MadisonN/A

See all isosulfan blue clinical trials

US Patents and Regulatory Information for isosulfan blue

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covidien LYMPHAZURIN isosulfan blue SOLUTION;SUBCUTANEOUS 018310-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Somerset Theraps Llc ISOSULFAN BLUE isosulfan blue SOLUTION;SUBCUTANEOUS 210558-001 Jul 12, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Beloteca ISOSULFAN BLUE isosulfan blue SOLUTION;SUBCUTANEOUS 210714-001 Jan 16, 2019 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Msn ISOSULFAN BLUE isosulfan blue SOLUTION;SUBCUTANEOUS 216090-001 Sep 16, 2022 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Institutional ISOSULFAN BLUE isosulfan blue SOLUTION;SUBCUTANEOUS 090874-001 Jul 20, 2010 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma ISOSULFAN BLUE isosulfan blue SOLUTION;SUBCUTANEOUS 206831-001 Feb 2, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.